Top Tweets for #asc024
We're excited to be joined by Jens Huober, Isabell Witzel, and Konstantin Dedes for an insightful discussion on the latest therapeutic advances for #BreastCancer following #ASC024.
⏰ July 2nd at 6PM CEST
Join the discussion for free - it's CME-certified ⬇️
Cancer du sein : Décryptage par @LeFigaro_Sante des 3 études cliniques prometteuses présentées par l'@institut_curie au congrès de l'#ASC024 qui pourraient améliorer considérablement la prise en charge des #cancersdusein dits triple négatifs ↘️
https://t.co/uC6H7FCm3a
Dr. Wang PhIII TNTCRT high-risk StII-III #LARC RCT 1:1 TNT w/long-course RT vs CRT (47-49% T4a) ➡️ pCR rate 27.51 vs 9.84%, absolute benefit 9% in DFS w/TNT over CRT and similar locoregional failure, but no OS difference
#ASCO24 @OncoAlert @manjuggm
Nikki Williams @nciccr_gmb @NCIResearchCtr presented data from a study of Prospective #PSMA🩻 Monitoring #BCR #ProstateCancer #ASC024
https://t.co/0RQSZEhdoI
Pts are willing to defer therapy after a discussion of known risks/benefits
Accrual continues
https://t.co/xCEFXIDiRK
#ASC024 Plenary
Ph III ADRIATIC trial of consolidation Durva +/- Treme post cCRT for LS SCLC:
⏺️mOS 55.9 vs 33.4mo (HR 0.73, p=0.01)
⏺️mPFS 16.6 vs 9.2mo
Had a fantastic experience presenting my findings on real world outcomes of Pembrolizumab vs Cetuximab based therapy in R/M HNSCC at #ASC024 Grateful for the valuable feedback and discussions with experts in the field. Special thanks to @GilbertodeCas13 for his valuable feedback
This morning @ASCO, Massey fellow @HamediZahra, M.D., presented findings comparing the efficacy of multiple treatment regimens for head and neck tumors.
"Real-world data from U.S. patients confirms superiority of pembrolizumab-based therapy over cetuximab." #ASCO24
PATRICIA Cohort C wonderfully presented by Eva Ciruelos
Palbo+ H+ ET vs TPC in PAM50 LumA/B HR+/HER2+ ABC, at least 1 prior line tx
n=73
2 median prior lines
PFS improved 7.5 vs 9.1 mo, HR 0.52, p=0.03
@OncoAlert @_SOLTI #ASC024 #bcsm
🎯 This slide of millions: what does the sequencing of HR+ HER2- metastatic breast cancer look like after #ASC024 ?
Every day more options⏩
Remembering the possibility of re-exposing to CDK4/6i 👇🏻
@OncoAlert
Important study presented today at #ASC024 in the HR+ HER2- postMONARCH metastatic breast cancer oral session: Abemaciclib + Fulvestrant after progression to CDK4/6i+ endocrine therapy.
@OncoAlert
Appreciated the balanced take and this study! This space will continue to be where the art of medicine and nuanced multidisplinary discussions are key. #lcsm #ASC024
Congrats to @IyengarPuneeth and @NRGonc for LU002. Important study showing SBRT does not synergize with IO in mNSCLC. #ASCO2024, #MedIQASCO2024
🏃♀️Did someone say #ExerciseOncology?
🏃♀️This poster by Dr. @PauloBergerot on the "Effect of a 12-week remote exercising program on #QOL & symptoms of older pts with cancer in Brazil will blow your minds!
🏃♀️Got questions? Stop by Hall A, PB #494; June 1st, 9:00AM-12:00PM #ASC024
🚨Anyone looking for a poster on #YoungLungCancer at #ASC024⁉️
🚨Head over to Hall A, #PB 233, where Dr. @NarjustFlorezMD will present updates on "Young Lung Cancer: Psychosocial Needs Assessment"💯
🚨You don't want to miss it!
🗓️June 3rd, 2024; 1:30-4:30PM
#ASC024 @ASCO 👩⚕️👩🏾⚕️👩🏻⚕️👩🏿⚕️
Stellar line up of events in the Women Networking Center!
Check the events, and join in on the conversation
@AnaVManana @fumikochino @DeepaRangachari
@HemOncWomenDocs @ASCOPres @jrgralow @OncoAlert
Join us Saturday 6/1 at 1:00 PM at #ASCO24 Women’s Networking Center for a panel discussion on “Strategic Visibility: Elevating Visibility Through Personal Branding”
Honored to share my experience & learn from @fumikochino @DeepaRangachari @jackiebrown_MD
Don’t miss the Women’s Networking Lounge events 🔥🔥
#WomenInMedicine #WomenInOncology
@HemOncWomenDocs @ASCO @UCSFCancer @WomeninOnc
#Covid19 accelerated the use of decentralized trial (DCT) elements in cancer trials. Our study is the first to evaluate DCT elements used in cancer trials submitted to @FDAOncology & led to marketing approval.
Check out our @ASCO abstract - https://t.co/84iJnpRD58
#ASC024
The PACIFIC-2 trial by @astrazeneca has generated confusion, surprise, and even seemed to strike a nerve 😬 among Lung Cancer Specialists. Follow the powerful discussions of Key Opinion Leaders in Thoracic Surgery, Medical Oncology, and Radiation Oncology. #lcsm #asc024
👉https://t.co/8OZWEJrWLb
🚨 #ASCO24 abstract titles are out!
🥁 Exciting #PlenarySession, specially for #LCSM community!
1⃣ ESOPEC, periop chemo (FLOT) vs. neoadj chemoRT (CROSS) for esophageal adeno #ESOCSM
2⃣ NADINA, neoadj ipilimumab + nivolumab vs. adj nivolumab for stage III melanoma #MELSM
3⃣ Telehealth vs. in-person early #PallOnc for pts with advanced #LungCancer
4⃣ LAURA, osimertinib post-chemoRT in unresectable EGFRm NSCLC
5⃣ ADRIATIC, consolidation durvalumab for LS-SCLC
@UCSFCancer @ASCO
Last Seen Hashtags on Sotwe
キャベツはうちの
Seen from Japan
sislitravesti
Seen from Italy
Teenagegirls filter:videos
Seen from Turkey
hijabi
Seen from United Kingdom
momson nolimit filter:videos
Seen from South Africa
ngentottante
Seen from Singapore
monkeyapp flashes
Seen from Italy
รับงานปากเกร็ด
Seen from Japan
NATGAS
Seen from United States
madreEhijo
Seen from Spain
Most Popular Users
Elon Musk 
@elonmusk
240.9M followers
Barack Obama
@barackobama
119.2M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Cristiano Ronaldo
@cristiano
111.4M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
97.9M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91.1M followers
KATY PERRY
@katyperry
88.1M followers
Taylor Swift
@taylorswift13
82M followers
Lady Gaga
@ladygaga
73.5M followers
Virat Kohli
@imvkohli
70.6M followers
Kim Kardashian
@kimkardashian
70M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
64.1M followers
Neymar Jr
@neymarjr
63.4M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.9M followers
Selena Gomez
@selenagomez
61.2M followers
X
@x
60.8M followers